Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gorman Rupp (GRC) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Gorman Rupp (GRC) over the last 16 years, with Q3 2025 value amounting to -$367000.0.

  • Gorman Rupp's Change in Accured Expenses fell 48253.97% to -$367000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year increase of 14004.99%. This contributed to the annual value of -$3.6 million for FY2024, which is 15704.56% down from last year.
  • Latest data reveals that Gorman Rupp reported Change in Accured Expenses of -$367000.0 as of Q3 2025, which was down 48253.97% from $33000.0 recorded in Q2 2025.
  • Gorman Rupp's Change in Accured Expenses' 5-year high stood at $5.4 million during Q3 2021, with a 5-year trough of -$4.6 million in Q4 2022.
  • Over the past 5 years, Gorman Rupp's median Change in Accured Expenses value was $272000.0 (recorded in 2024), while the average stood at $506263.2.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first skyrocketed by 180552.49% in 2022, then crashed by 48253.97% in 2025.
  • Over the past 5 years, Gorman Rupp's Change in Accured Expenses (Quarter) stood at -$1.2 million in 2021, then plummeted by 266.64% to -$4.6 million in 2022, then surged by 53.19% to -$2.1 million in 2023, then skyrocketed by 112.71% to $272000.0 in 2024, then tumbled by 234.93% to -$367000.0 in 2025.
  • Its Change in Accured Expenses stands at -$367000.0 for Q3 2025, versus $33000.0 for Q2 2025 and $2.5 million for Q1 2025.